14 June 2022
STAT News has interviewed Jennifer Cohn, Global Access Project Leader at GARDP, about a “first-of-its-kind arrangement” between Shionogi and GARDP “to license an antibiotic to dozens of mostly low- and middle-income countries in a bid to combat antimicrobial resistance.”